Nasal drug delivery is a form of peripheral administration and IL-13 is a pleiotropic type 2 cytokine that contributes to eosinophil chemotaxis in eosinophilic esophagitis (EOE) and atopic dermatitis (AD) [37, 38]. This evidence concerns the gene IL13 and atopic eczema.